When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Exelixis (NASDAQ:EXEL) announces that its partner Ipsen (OTCPK:IPSEF) received a positive opinion from the CHMP, for CABOMETYX (cabozantinib) tablets as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib.
More news on: Exelixis, Inc., Ipsen S.A., Ipsen S.A. ADR, Healthcare stocks news, Stocks on the move,